- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-03-0002081

Zabetas Pharmaceuticals Private Limited
About Zabetas Pharmaceuticals Private Limited
Data last updated:
Zabetas Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2015PTC285716. Its GSTIN is 23AAACZ8796R1Z7 (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manish Kumar and Kajal Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. K – II/ 327 – B Khasra No.33/2 Sangam Vihar, New Delhi, Delhi, India – 110062.
As per the financials filed for FY 2024, the company reported a revenue of ₹10.65 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹11,842 (net margin 1.1%) and EBITDA of ₹51,716 (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 23% over five years.
As per MCA filings, the company has open charges of ₹4.5 Lakh on record.
Zabetas Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0002081). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Zabetas Pharmaceuticals
Contact details
Zabetas Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. K – II/ 327 – B Khasra No.33/2 Sangam Vihar, New Delhi, Delhi, India – 110062
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Zabetas Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zabetas Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Zabetas Pharmaceuticals Private Limited, buy the company report.
Financials of Zabetas Pharmaceuticals Private Limited
FY 2025 filings availableZabetas Pharmaceuticals Private Limited reported revenue of ₹10.65 Lakh (up 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 6% growth in the latest year. EBITDA rose 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹51,716 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11,842 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zabetas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zabetas Pharmaceuticals Private Limited
Zabetas Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Kumar | Director | 28 Sep 2015 | 11 Years 1 Months | Current |
| Kajal Kumari | Director | 06 Apr 2022 | 4 Years 7 Months | Current |
Auditor
Zabetas Pharmaceuticals Private Limited is audited by HARSHIT RAWAT & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HARSHIT RAWAT & CO | FY 2019 | 021345C |
Shareholding
The shareholding of Zabetas Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Zabetas Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Jun 2025 | 101113348 | Canara Bank | ₹4.5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Zabetas Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zabetas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zabetas Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAACZ8796R1Z7 | Madhya Pradesh | Active | 04 Dec 2018 |
To see the full GST registrations and return filing status of Zabetas Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zabetas Pharmaceuticals Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Kajal Kumari was appointed as Director on 06 Apr 2022.
Frequently asked questions
Zabetas Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 September 2015 (11+ years old) and is registered under CIN U24100DL2015PTC285716.
Zabetas Pharmaceuticals has 2 current directors:
- Manish Kumar - Director
- Kajal Kumari - Director
The latest financial statements of Zabetas Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Zabetas Pharmaceuticals is 23AAACZ8796R1Z7, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Zabetas Pharmaceuticals is U24100DL2015PTC285716. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zabetas Pharmaceuticals was incorporated on 28 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Kajal Kumari was appointed as Director on 06 Apr 2022. Meera Kumari ceased to be Director on 06 Apr 2022. Alok Ranjan ceased to be Director on 22 Jun 2018. Zabetas Pharmaceuticals has 5 board changes on record in total.
Yes, Zabetas Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0002081).
The registered office of Zabetas Pharmaceuticals is at Plot No. K – II 327 – B Khasra No.332 Sangam Vihar, New Delhi, Delhi, India – 110062.
Zabetas Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

